SG
IBB icon

StoneX Group’s iShares Biotechnology ETF IBB Stock Holding History

StoneX Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Sell
1,339
-1,953
-59% -$336K 0.01% 936
2026
Q1 		$553K Buy
3,292
+520
+19% +$88.9K 0.03% 391
2025
Q4 		$469K Buy
2,772
+919
+50% +$149K 0.02% 551
2025
Q3 		$268K Sell
1,853
-276
-13% -$37.7K 0.01% 732
2025
Q2 		$269K Sell
2,129
-15
-0.7% -$1.84K 0.01% 692
2025
Q1 		$274K Buy
2,144
+245
+13% +$33.2K 0.02% 674
2024
Q4 		$251K Sell
1,899
-248
-12% -$34.9K 0.01% 677
2024
Q3 		$313K Buy
2,147
+91
+4% +$13.2K 0.02% 461
2024
Q2 		$282K Sell
2,056
-14
-0.7% -$1.87K 0.02% 478
2024
Q1 		$284K Sell
2,070
-32
-2% -$4.37K 0.03% 437
2023
Q4 		$286K Sell
2,102
-154
-7% -$18.8K 0.03% 423
2023
Q3 		$276K Sell
2,256
-424
-16% -$53.9K 0.03% 427
2023
Q2 		$340K Sell
2,680
-12
-0.4% -$1.56K 0.04% 374
2023
Q1 		$348K Sell
2,692
-134
-5% -$17.5K 0.04% 372
2022
Q4 		$371K Sell
2,826
-110
-4% -$14.2K 0.04% 348
2022
Q3 		$343K Sell
2,936
-1,613
-35% -$200K 0.05% 343
2022
Q2 		$535K Sell
4,549
-1,801
-28% -$214K 0.07% 275
2022
Q1 		$827K Buy
6,350
+3,867
+156% +$504K 0.07% 251
2021
Q4 		$379K Buy
2,483
+248
+11% +$38.4K 0.04% 350
2021
Q3 		$361K Buy
2,235
+444
+25% +$74.7K 0.05% 315
2021
Q2 		$293K Buy
1,791
+463
+35% +$71.3K 0.04% 362
2021
Q1 		$200K Buy
+1,328
New +$211K 0.04% 399
2019
Q2 		– Sell
-1,798
Closed -$201K – 247
2019
Q1 		$201K Buy
+1,798
New +$197K 0.15% 218
2018
Q4 		– Sell
-2,002
Closed -$244K – 219
2018
Q3 		$244K Buy
+2,002
New +$236K 0.18% 196

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

StoneX Group's IBB Position: Q2 2026 in Review

StoneX Group reduced its iShares Biotechnology ETF (IBB) stake by 59% in Q2 2026, selling an estimated $336K and leaving 1,339 shares worth $255K. The position accounts for 0.01% of the portfolio, ranked #936.

StoneX Group first reported a position in IBB in Q3 2018 and has held it in 24 quarters since. The position peaked at $827K in Q1 2022. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • StoneX Group held 1,339 shares of iShares Biotechnology ETF worth $255K as of Q2 2026.
  • StoneX Group sold 1,953 iShares Biotechnology ETF shares in Q2 2026, an estimated $336K.
  • iShares Biotechnology ETF made up 0.01% of StoneX Group's portfolio in Q2 2026, its #936 holding.
  • StoneX Group first reported a position in iShares Biotechnology ETF in Q3 2018 and has held it in 24 quarters since.
  • StoneX Group's iShares Biotechnology ETF position peaked at $827K in Q1 2022.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.